Indian stock markets experienced significant declines on Wednesday. Escalating Iran-US tensions and tariff threats spooked investors, causi...

ET Wealth spoke to five investors who bought NSE shares long before the IPO became a certainty. Their stories are a reminder of the opportu...

Samir Arora-backed Helios Mid Cap Fund added Groww parent Billionbrains Garage Ventures and four other stocks to its June portfolio, while ...

Piramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, resulting in a F...

The company made a Rs 3540 crore provision on its AIF investments registering a loss of Rs 2378 crore in December 2023 from a profit of Rs ...

Ambani & Piramal were all smiles as they posed for the paps.

Isha Ambani-Piramal and Anand Piramal on Sunday announced that the couple have been blessed with a set of twins on Saturday, November 19, n...

In our company we always make public whatever it is to our shareholders in the right manner.

The company made its stand clear through a communication to exchanges.

"It is obviously not true," Swati Piramal, vice chairperson, Piramal Enterprises, told ETPanache, "We do not do anything that does not conf...

Piramal will hold 51 per cent of the equity share capital of the proposed joint venture company and the remaining 49 per cent will be held ...

The Piramal Healthcare group will get a board seat after its purchase of additional 5.5% in Vodafone India.

IVRCL Infrastructures and Projects is negotiating with potential bidders to offload its 55% stake in industrial equipment unit Hindustan Do...

Given the size of the company, there is a lot of news that keeps coming and the stock does not do very much. So that combination is usually...

Shrikanth Shetty, Head, Equity Advisory, Unicon Investment Solutions, in an interview to ET NOW said 500 to 550 is what would be a fair val...

GlaxoSmithKline is in early stages of discussions to acquire Indian generic drug maker Piramal Healthcare for around $1.5 billion.

British pharma major GlaxoSmithKline Plc is in early stages of discussions to acquire Indian generic drug maker Piramal Healthcare for arou...